The Wang Lab was established at Eastern Institute of Technology, Ningbo, in January 2026, opening a new chapter in interdisciplinary chemical and biomedical research.
Led by Professor Wei Wang, the group brings together researchers working across precision organic synthesis, chemical biology, and AI-driven drug discovery. Its research focuses on developing molecular tools and therapeutic approaches for challenging problems in cancer, neurodegenerative diseases, and aging.
The establishment of the group creates a collaborative setting in which ideas from chemistry, biology, and artificial intelligence can inform the design and discovery of next-generation therapeutics.